Literature DB >> 15618197

Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.

Shira D P Rabin1, Alan R Hauser.   

Abstract

ExoU, a potent patatin-like phospholipase, causes rapid cell death following its injection into host cells by the Pseudomonas aeruginosa type III secretion system. To better define regions of ExoU required for cytotoxicity, transposon-based linker insertion mutagenesis followed by site-directed mutagenesis of individual residues was employed by using a Saccharomyces cerevisiae model system. Random insertion of five amino acids identified multiple regions within ExoU that are required for cell killing. Five regions were chosen for further characterization: three corresponded to the oxyanion hole, hydrolase motif, and catalytic aspartate motif of the patatin-like domain within the N-terminal half of ExoU; one corresponded to an uncharacterized part of the patatin-like domain; and one corresponded to a region near the C terminus. Specific individual amino acid substitutions in each of the four N-terminal regions prevented killing of yeast and significantly reduced phospholipase activity. Whereas five amino acid insertions in the fifth region near the C terminus markedly reduced cytotoxicity and phospholipase activity, substitution of individual amino acids did not abolish either activity. To determine whether each of the five identified regions of ExoU was also essential for cytotoxicity in human cells, representative mutant forms of ExoU fused to green fluorescent protein were expressed in HeLa cells. These variants of ExoU were readily visualized and caused minimal cytotoxicity to HeLa cells, while wild-type ExoU fused to green fluorescent protein induced significant cell lysis and no detectable fluorescence. Thus, a minimum of five regions, including one which is well removed from the patatin-like domain, are required for the cytotoxicity and phospholipase activity of ExoU.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618197      PMCID: PMC538981          DOI: 10.1128/IAI.73.1.573-582.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.

Authors:  A J Vallis; V Finck-Barbançon; T L Yahr; D W Frank
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998.

Authors: 
Journal:  Am J Infect Control       Date:  1998-10       Impact factor: 2.918

3.  ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.

Authors:  V Finck-Barbançon; J Goranson; L Zhu; T Sawa; J P Wiener-Kronish; S M Fleiszig; C Wu; L Mende-Mueller; D W Frank
Journal:  Mol Microbiol       Date:  1997-08       Impact factor: 3.501

4.  Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.

Authors:  V Finck-Barbançon; D W Frank
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

5.  Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.

Authors:  A R Hauser; J N Engel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 6.  The exoenzyme S regulon of Pseudomonas aeruginosa.

Authors:  D W Frank
Journal:  Mol Microbiol       Date:  1997-11       Impact factor: 3.501

7.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism.

Authors:  A Dessen; J Tang; H Schmidt; M Stahl; J D Clark; J Seehra; W S Somers
Journal:  Cell       Date:  1999-04-30       Impact factor: 41.582

9.  Visualization of coupled protein folding and binding in bacteria and purification of the heterodimeric complex.

Authors:  Haoyong Wang; Shaorong Chong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

10.  The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.

Authors:  Hiromi Sato; Dara W Frank; Cecilia J Hillard; Jimmy B Feix; Ravi R Pankhaniya; Kiyoshi Moriyama; Viviane Finck-Barbançon; Adam Buchaklian; Ming Lei; Roy M Long; Jeanine Wiener-Kronish; Teiji Sawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  41 in total

1.  Functional characterization of a phospholipase A(2) homolog from Rickettsia typhi.

Authors:  M Sayeedur Rahman; Nicole C Ammerman; Khandra T Sears; Shane M Ceraul; Abdu F Azad
Journal:  J Bacteriol       Date:  2010-04-30       Impact factor: 3.490

2.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages.

Authors:  Dana G Mordue; Casey F Scott-Weathers; Crystal M Tobin; Laura J Knoll
Journal:  Mol Microbiol       Date:  2006-12-11       Impact factor: 3.501

5.  Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Vincent T Lee; Stefan Pukatzki; Hiromi Sato; Eriya Kikawada; Anastasia A Kazimirova; Jin Huang; Xiaohua Li; Jonathan P Arm; Dara W Frank; Stephen Lory
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

6.  Activation of ExoU phospholipase activity requires specific C-terminal regions.

Authors:  Katherine M Schmalzer; Marc A Benson; Dara W Frank
Journal:  J Bacteriol       Date:  2010-01-22       Impact factor: 3.490

7.  Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Authors:  Marc A Benson; Steven M Komas; Katherine M Schmalzer; Monika S Casey; Dara W Frank; Jimmy B Feix
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

10.  A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity.

Authors:  Marc A Benson; Katherine M Schmalzer; Dara W Frank
Journal:  Clin Chim Acta       Date:  2009-11-10       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.